Codes / ICD10CM / M30.0

M30.0 Polyarteritis nodosa

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Polyarteritis nodosa

Summary

Polyarteritis nodosa is a rare systemic vasculitis affecting medium-sized arteries, leading to inflammation, aneurysm formation, and potential organ damage. It primarily targets the kidneys, skin, nerves, and gastrointestinal tract, with symptoms varying based on the organs involved.

Causes

The condition is often associated with immune complex deposition in arterial walls, though the exact trigger remains unclear. In some cases, hepatitis B virus infection is linked to its development, suggesting an infectious or autoimmune mechanism.

Risk Factors

  • Age: Most commonly diagnosed in adults aged 40–60.
  • Sex: Slightly more prevalent in males.
  • Infection: Prior hepatitis B or C infection increases risk.
  • Autoimmune conditions: May coexist with other vasculitides.

Symptoms

  • Fever, fatigue, and weight loss.
  • Skin manifestations (e.g., livedo reticularis, nodules, ulcers).
  • Peripheral neuropathy (numbness, weakness, pain).
  • Abdominal pain, nausea, or gastrointestinal bleeding.
  • Kidney involvement (elevated blood pressure, proteinuria).
  • Joint or muscle pain.

Diagnosis

Diagnosis relies on clinical suspicion, imaging (e.g., angiography showing aneurysms), and biopsy of affected tissue (e.g., skin, nerve, or kidney). Blood tests may reveal elevated inflammatory markers, and serology for hepatitis B/C is often performed.

Treatment Options

  • Immunosuppressants: Corticosteroids (e.g., prednisone) to reduce inflammation.
  • Cytotoxic agents: Cyclophosphamide for severe cases.
  • Antiviral therapy: For hepatitis B-associated cases.
  • Supportive care: Blood pressure management, pain relief, and organ-specific interventions.

Prognosis and Follow-Up

Prognosis depends on disease severity and organ involvement. Early treatment improves outcomes, but relapses or complications (e.g., renal failure) may occur. Regular monitoring of organ function and inflammatory markers is essential.

Complications

  • Irreversible organ damage (e.g., kidney failure, neuropathy).
  • Gastrointestinal perforation or hemorrhage.
  • Hypertension or heart involvement.
  • Increased risk of infection due to immunosuppression.

Lifestyle & Prevention

  • Avoid known triggers (e.g., hepatitis B exposure).
  • Manage comorbidities (e.g., hypertension, diabetes).
  • Regular medical follow-up to monitor organ function.
  • Lifestyle modifications to support overall health (e.g., balanced diet, stress reduction).

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., sudden abdominal pain, unexplained fever, or neurological changes). Ongoing monitoring is critical for those with diagnosed disease to address complications early.

Tips for Medical Coders

Document the specific organ systems affected (e.g., renal, gastrointestinal) and any associated conditions (e.g., hepatitis B) to support accurate coding. Ensure clinical notes align with the systemic nature of the vasculitis and exclude other vasculitides when applicable.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

M30.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.